The Cancer Letter

Inside information on cancer research and drug development

Vol.
31
No.
10
March 11, 2005Mar 11, 2005
Free
DOWNLOAD THE PDF

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

Proof of principle needed before launching “big science” program, advisors say.

Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account